Sign in
4

Changes in Ownership

IDEAYA Biosciences, Inc. Filed Acc 0001610717-23-000258

Chief Legal Officer sold 3,837 shares at an average $30.03 ($115,222)

  • Chief Legal Officer acquired 3,837 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Throne Jason · Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-01 Exercise or conversion : show line 1 in the form 10b5-1 +2,100 $12.86 $27,006 2,100 D
2023-09-01 Sale : show line 2 in the form 10b5-1 −2,100 $30.03 $63,063 0 D
2023-09-05 Exercise or conversion : show line 3 in the form 10b5-1 +1,737 $12.86 $22,338 1,737 D
2023-09-05 Sale : show line 4 in the form 10b5-1 −1,737 $30.03 $52,160 0 D
Open-market sales · 3,837 sh · avg $30.03 · $115,222

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-09-01 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −2,100 56,650 D
2023-09-05 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −1,737 54,913 D
Loading xslF345X05/form4.xml…